Clinical Trials Browser

Phase 1/2 × Interventional × CYC065 × Clear all

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT05168904 2024-02-08

A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)

Phase 1/2 Suspended

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes